Results 211 to 220 of about 22,516 (228)

Redefining the therapeutic landscape for CRPC

Nature Reviews Urology, 2011
Carmel Pezaro, Gerhardt Attard
openaire   +1 more source

[Progress of the treatment for CRPC].

Nihon rinsho. Japanese journal of clinical medicine, 2016
Seiichiro, Ozono, Hiroshi, Furuse
openaire   +1 more source

Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype

Oncogene, 2013
Theresa E Hickey, Alastair D Lamb, David E. Neal   +2 more
exaly  

Sargramostim (GM-CSF) and lenalidomide in castration-resistant prostate cancer (CRPC): Results from a phase I-II clinical trial

Urologic Oncology: Seminars and Original Investigations, 2014
Robert Dreicer, Jorge A Garcia, Allison Tyler   +2 more
exaly  

Targeting apoptosis resistance in CRPC

Nature Reviews Urology, 2016
openaire   +1 more source

Evaluation of glucocorticoid-related genes reveals GPD1 as a therapeutic target and regulator of sphingosine 1-phosphate metabolism in CRPC

Cancer Letters
Zongren Wang, Yu-Xiang Liang, Zhihao Zou
exaly  

Evaluating CRPC Definition: Comparing Upfront ARSI and Conventional Hormonal Therapy for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Real World Propensity Score Matched Cohort

Prostate
Shunsuke Tsuzuki, Fumihiko Urabe, Kojiro Tashiro   +2 more
exaly  

Steroid enzyme mutated in CRPC

Nature Reviews Urology, 2013
openaire   +1 more source

Docetaxel versus androgen receptor signaling inhibitor (ARSI) against chemo-naïve castration-resistant prostate cancer (CRPC): propensity score matched analysis in real world

International Urology and Nephrology
Takahiro Kimura, Keiichiro Mori, Tatsuya Shimomura   +2 more
exaly  

La CRPC

2010
openaire   +1 more source